Efficacy and safety of combination therapy with latanoprost after a change in therapeutic regimen from timolol to brinzolamide in Japanese adult patients with primary open-angle glaucoma and ocular hypertension: open, non-randomized 12-week study
PURPOSE: To compare the efficacy of brinzolamide in Japanese patients with primary open-angle glaucoma (POAG) or ocular hypertension (OH) after a change from timolol in combination therapy with latanoprost. METHODS: A 12-week, prospective, open-label, comparative study was performed in 20 patients [...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699801/ https://www.ncbi.nlm.nih.gov/pubmed/19668419 |
_version_ | 1782168536060264448 |
---|---|
author | Ishikawa, Shusaku Nakamura, Yoshimi Nakamura, Yuko Sakai, Hiroshi Sawaguchi, Shoichi Terashima, Kazuo Kanno, Makoto Yamashita, Hidetoshi |
author_facet | Ishikawa, Shusaku Nakamura, Yoshimi Nakamura, Yuko Sakai, Hiroshi Sawaguchi, Shoichi Terashima, Kazuo Kanno, Makoto Yamashita, Hidetoshi |
author_sort | Ishikawa, Shusaku |
collection | PubMed |
description | PURPOSE: To compare the efficacy of brinzolamide in Japanese patients with primary open-angle glaucoma (POAG) or ocular hypertension (OH) after a change from timolol in combination therapy with latanoprost. METHODS: A 12-week, prospective, open-label, comparative study was performed in 20 patients [11 males and 9 females, mean age of 64.5 ± 11.0 (SD)y] with POAG or OH treated with both latanoprost once daily and timolol 0.5% twice daily. During the study brinzolamide was substituted for timolol. Intraocular pressure (IOP) was measured at baseline, 4, 8, and 12 weeks. Blood pressure (BP), pulse rate (PR), and adverse events were also recorded. RESULTS: IOPs at baseline, 4, 8, and 12 weeks were 18.6 ± 2.1 mmHg, 17.8 ± 2.6 mmHg, 17.4 ± 2.5 mmHg, and 17.3 ± 3.5 mmHg, respectively. IOP reduction at 4 and 8 weeks was statistically significant (p < 0.05). The PR was significantly increased at 12 weeks (p < 0.01), but BP was not significantly affected. Four ocular adverse events were noted, but all were mild and transient. CONCLUSIONS: Substituting brinzolamide 1% for timolol 0.5% in combination therapy with latanoprost 0.005% demonstrated significant IOP reduction with improvement in PR with POAG or OH. Combination therapy using latanoprost and brinzolamide may be recommended for better IOP control with fewer systemic adverse events. |
format | Text |
id | pubmed-2699801 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-26998012009-08-10 Efficacy and safety of combination therapy with latanoprost after a change in therapeutic regimen from timolol to brinzolamide in Japanese adult patients with primary open-angle glaucoma and ocular hypertension: open, non-randomized 12-week study Ishikawa, Shusaku Nakamura, Yoshimi Nakamura, Yuko Sakai, Hiroshi Sawaguchi, Shoichi Terashima, Kazuo Kanno, Makoto Yamashita, Hidetoshi Clin Ophthalmol Original Research PURPOSE: To compare the efficacy of brinzolamide in Japanese patients with primary open-angle glaucoma (POAG) or ocular hypertension (OH) after a change from timolol in combination therapy with latanoprost. METHODS: A 12-week, prospective, open-label, comparative study was performed in 20 patients [11 males and 9 females, mean age of 64.5 ± 11.0 (SD)y] with POAG or OH treated with both latanoprost once daily and timolol 0.5% twice daily. During the study brinzolamide was substituted for timolol. Intraocular pressure (IOP) was measured at baseline, 4, 8, and 12 weeks. Blood pressure (BP), pulse rate (PR), and adverse events were also recorded. RESULTS: IOPs at baseline, 4, 8, and 12 weeks were 18.6 ± 2.1 mmHg, 17.8 ± 2.6 mmHg, 17.4 ± 2.5 mmHg, and 17.3 ± 3.5 mmHg, respectively. IOP reduction at 4 and 8 weeks was statistically significant (p < 0.05). The PR was significantly increased at 12 weeks (p < 0.01), but BP was not significantly affected. Four ocular adverse events were noted, but all were mild and transient. CONCLUSIONS: Substituting brinzolamide 1% for timolol 0.5% in combination therapy with latanoprost 0.005% demonstrated significant IOP reduction with improvement in PR with POAG or OH. Combination therapy using latanoprost and brinzolamide may be recommended for better IOP control with fewer systemic adverse events. Dove Medical Press 2008-12 2008-12 /pmc/articles/PMC2699801/ /pubmed/19668419 Text en © 2008 Ishikawa et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Ishikawa, Shusaku Nakamura, Yoshimi Nakamura, Yuko Sakai, Hiroshi Sawaguchi, Shoichi Terashima, Kazuo Kanno, Makoto Yamashita, Hidetoshi Efficacy and safety of combination therapy with latanoprost after a change in therapeutic regimen from timolol to brinzolamide in Japanese adult patients with primary open-angle glaucoma and ocular hypertension: open, non-randomized 12-week study |
title | Efficacy and safety of combination therapy with latanoprost after a change in therapeutic regimen from timolol to brinzolamide in Japanese adult patients with primary open-angle glaucoma and ocular hypertension: open, non-randomized 12-week study |
title_full | Efficacy and safety of combination therapy with latanoprost after a change in therapeutic regimen from timolol to brinzolamide in Japanese adult patients with primary open-angle glaucoma and ocular hypertension: open, non-randomized 12-week study |
title_fullStr | Efficacy and safety of combination therapy with latanoprost after a change in therapeutic regimen from timolol to brinzolamide in Japanese adult patients with primary open-angle glaucoma and ocular hypertension: open, non-randomized 12-week study |
title_full_unstemmed | Efficacy and safety of combination therapy with latanoprost after a change in therapeutic regimen from timolol to brinzolamide in Japanese adult patients with primary open-angle glaucoma and ocular hypertension: open, non-randomized 12-week study |
title_short | Efficacy and safety of combination therapy with latanoprost after a change in therapeutic regimen from timolol to brinzolamide in Japanese adult patients with primary open-angle glaucoma and ocular hypertension: open, non-randomized 12-week study |
title_sort | efficacy and safety of combination therapy with latanoprost after a change in therapeutic regimen from timolol to brinzolamide in japanese adult patients with primary open-angle glaucoma and ocular hypertension: open, non-randomized 12-week study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699801/ https://www.ncbi.nlm.nih.gov/pubmed/19668419 |
work_keys_str_mv | AT ishikawashusaku efficacyandsafetyofcombinationtherapywithlatanoprostafterachangeintherapeuticregimenfromtimololtobrinzolamideinjapaneseadultpatientswithprimaryopenangleglaucomaandocularhypertensionopennonrandomized12weekstudy AT nakamurayoshimi efficacyandsafetyofcombinationtherapywithlatanoprostafterachangeintherapeuticregimenfromtimololtobrinzolamideinjapaneseadultpatientswithprimaryopenangleglaucomaandocularhypertensionopennonrandomized12weekstudy AT nakamurayuko efficacyandsafetyofcombinationtherapywithlatanoprostafterachangeintherapeuticregimenfromtimololtobrinzolamideinjapaneseadultpatientswithprimaryopenangleglaucomaandocularhypertensionopennonrandomized12weekstudy AT sakaihiroshi efficacyandsafetyofcombinationtherapywithlatanoprostafterachangeintherapeuticregimenfromtimololtobrinzolamideinjapaneseadultpatientswithprimaryopenangleglaucomaandocularhypertensionopennonrandomized12weekstudy AT sawaguchishoichi efficacyandsafetyofcombinationtherapywithlatanoprostafterachangeintherapeuticregimenfromtimololtobrinzolamideinjapaneseadultpatientswithprimaryopenangleglaucomaandocularhypertensionopennonrandomized12weekstudy AT terashimakazuo efficacyandsafetyofcombinationtherapywithlatanoprostafterachangeintherapeuticregimenfromtimololtobrinzolamideinjapaneseadultpatientswithprimaryopenangleglaucomaandocularhypertensionopennonrandomized12weekstudy AT kannomakoto efficacyandsafetyofcombinationtherapywithlatanoprostafterachangeintherapeuticregimenfromtimololtobrinzolamideinjapaneseadultpatientswithprimaryopenangleglaucomaandocularhypertensionopennonrandomized12weekstudy AT yamashitahidetoshi efficacyandsafetyofcombinationtherapywithlatanoprostafterachangeintherapeuticregimenfromtimololtobrinzolamideinjapaneseadultpatientswithprimaryopenangleglaucomaandocularhypertensionopennonrandomized12weekstudy |